SCHEMBL1562995

SCHEMBL1562995

NC(=O)Nc1cc(-c2ccc(F)cc2)sc1C(=O)N[C@H]1CCCNC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 18/20 1.00
MELK Q14680 3/20 0.84
PLK4 O00444 1/20 0.84
GAK O14976 1/20 0.84
JAK2 O60674 1/20 0.84
ULK1 O75385 1/20 0.84
RPS6KA4 O75676 1/20 0.84
STK10 O94804 1/20 0.84
PRKD3 O94806 1/20 0.84
MAP4K4 O95819 1/20 0.84
PAK4 O96013 1/20 0.84
ABL1 P00519 1/20 0.84
EGFR P00533 1/20 0.84
LCK P06239 1/20 0.84
FYN P06241 1/20 0.84
FES P07332 1/20 0.84
YES1 P07947 1/20 0.84
LYN P07948 1/20 0.84
RET P07949 1/20 0.84
HCK P08631 1/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31532554 0.95 CHEK1 (0.90) CHEK1MELKPLK4GAKJAK2
Azd-7762 SCHEMBL15105420 0.92 CHEK1 (1.00) CHEK1MELKPLK4GAKJAK2
Azd-7762 SCHEMBL1127614 0.92 CHEK1 (1.00) CHEK1MELKPLK4GAKJAK2
Azd-7762 SCHEMBL29388936 0.92 CHEK1 (1.00) CHEK1MELKPLK4GAKJAK2
Azd-7762 SCHEMBL1564574 0.92 CHEK1 (1.00) CHEK1MELKPLK4GAKJAK2
Azd-7762 SCHEMBL31517325 0.92 CHEK1 (1.00) CHEK1MELKPLK4GAKJAK2
SCHEMBL31532506 0.91 CHEK1 (1.00) CHEK1MELKPLK4GAKJAK2
SCHEMBL1562895 0.91 CHEK1 (1.00) CHEK1MELKPLK4GAKJAK2
SCHEMBL1564888 0.91 CHEK1 (1.00) CHEK1MELKPLK4GAKJAK2
Azd-7762 SCHEMBL19457662 0.91 MELK (1.00) CHEK1MELKPLK4GAKJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2305671-A1 Thiophene and thiazole derivatives as CHK1 inhibitors AstraZeneca AB (SE) 2011-04-06 EP disclosed